<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1726-8958</journal-id>
<journal-title><![CDATA[Revista Médica La Paz]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. La Paz]]></abbrev-journal-title>
<issn>1726-8958</issn>
<publisher>
<publisher-name><![CDATA[Colegio Médico de La Paz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1726-89582021000200080</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[TERAPIA ANTIMICROBIANA EMPIRICA EN PACIENTES CON COINFECCION BACTERIANA ASOCIADA A COVID 19]]></article-title>
<article-title xml:lang="en"><![CDATA[EMPIRICAL ANTIMICROBIAL THERAPY IN PATIENTS WITH BACTERIAL CO-INFECTION ASSOCIATED WITH COVID 19]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera Morales]]></surname>
<given-names><![CDATA[Guiselle Carol]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Urquizo Ayala]]></surname>
<given-names><![CDATA[Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,CNS  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital de Clínicas Unidad de Medicina Interna ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<volume>27</volume>
<numero>2</numero>
<fpage>80</fpage>
<lpage>86</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1726-89582021000200080&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1726-89582021000200080&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1726-89582021000200080&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Las evidencias sobre coinfecciones bacterianas y fúngicas en pacientes con infección por coronavirus informan un porcentaje general elevado de las mismas, en cualquier momento durante la hospitalización. Al tratarse de pacientes que con frecuencia requieren hospitalización prolongada y asistencia respiratoria, los antibióticos innecesarios en el momento de la hospitalización pueden aumentar el riesgo individual de Neumonía adquirida en el Hospital posterior causada por bacterias resistentes y otros eventos adversos. Por lo tanto, el uso adecuado de antimicrobianos se asocia a mayor éxito en el manejo de estos pacientes, Se revisan en este articulo las evidencias disponibles acerca del tratamiento antimicrobiano adecuado en los pacientes con COVID 19, con coinfecciones bacterianas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY Reviews of bacterial and fungal co-infections in patients with coronavirus infection report an overall high percentage of co-infections in COVID-19 patients at any time during hospitalization. As patients who often need prolonged hospitalization and respiratory support, unnecessary antibiotics at the time of hospitalization may increase the individual risk of subsequent hospital-acquired pneumonia caused by resistant bacteria and other adverse events. Therefore, the appropriate use of antimicrobials is associated with greater success in the management of these patients. This paper reviews the available evidence about the appropriate antimicrobial treatment in patients with COVID 19, with bacterial co-infections.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Coinfección en COVID 19]]></kwd>
<kwd lng="es"><![CDATA[resistencia bacteriana]]></kwd>
<kwd lng="es"><![CDATA[Terapia empírica en COVID 19]]></kwd>
<kwd lng="en"><![CDATA[COVID 19 coinfection]]></kwd>
<kwd lng="en"><![CDATA[bacterial resistance]]></kwd>
<kwd lng="en"><![CDATA[Empirical therapy in COVID 19]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albrich]]></surname>
<given-names><![CDATA[W.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Monnett]]></surname>
<given-names><![CDATA[D.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Harbarth]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes]]></article-title>
<source><![CDATA[Emerging Infectious Diseases]]></source>
<year>2004</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>514-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alos]]></surname>
<given-names><![CDATA[J.I.]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[M.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Garces]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Perianes]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data]]></article-title>
<source><![CDATA[Clinical Microbiology and Infection]]></source>
<year>2005</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>199-203</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arason]]></surname>
<given-names><![CDATA[V.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gunnlaugsson]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sigurdsson]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Erlendsdottir]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gudmundsson]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kristinsson]]></surname>
<given-names><![CDATA[K.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clonal spread of resistant pneumococci despite diminished antimicrobial use]]></article-title>
<source><![CDATA[Microbial Drug Resistance]]></source>
<year>2002</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>187-92</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arason]]></surname>
<given-names><![CDATA[V.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sigurdsson]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Erlendsdottir]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gudmundsson]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kristinsson]]></surname>
<given-names><![CDATA[K.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of antimicrobial use in the epidemiology of resistant penumococci: A 10-year follow up]]></article-title>
<source><![CDATA[Microbial Drug Resistance,]]></source>
<year>2006</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>169-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sieswerda]]></surname>
<given-names><![CDATA[Elske]]></given-names>
</name>
<name>
<surname><![CDATA[de Boer]]></surname>
<given-names><![CDATA[Mark G.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations for antibacterial therapy in adults with COVID-19 e an evidence based guideline]]></article-title>
<source><![CDATA[Clinical Microbiology and Infection]]></source>
<year>2021</year>
<volume>27</volume>
<page-range>61e66</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rawson]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[LSP]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ranganathan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Skolimowska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gilchrist]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bacterial and fungal co-infection in individuals with coronavirus a rapid review to support COVID-19 antimicrobial prescribing]]></article-title>
<source><![CDATA[Clin Infect Dis : Off Publ Inf Dis Soci Am]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalil]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Metersky]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Klompas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Muscedere]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sweeney]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of adults with hospital-acquired and ventilator-associated pneumonia 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society]]></article-title>
<source><![CDATA[Clin Infect Dis : Off Publ Inf Dis Soci Am]]></source>
<year>2016</year>
<volume>63</volume>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stevens]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dumyati]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fine]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[van Wijngaarden]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection]]></article-title>
<source><![CDATA[Clin Infect Dis : Off Publ Inf Dis Soci Am]]></source>
<year>2011</year>
<volume>53</volume>
<page-range>42e8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Schellevis]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Stobberingh]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Goossens]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pringle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and metaanalysis of the effects of antibiotic consumption on antibiotic resistance]]></article-title>
<source><![CDATA[BMC Infectious Diseases]]></source>
<year>2014</year>
<volume>14</volume>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[COVID 19: Uso y abuso de antibioticos]]></article-title>
<source><![CDATA[MEDSCAPE]]></source>
<year>05.1</year>
<month>0.</month>
<day>20</day>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Stuart]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of pneumonia in lower respiratory tract infections prospective cohort study of 3C cough complications]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schuetz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Beishuizen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Broyles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Procalcitonin-Guided Antibiotic Administration (PCT) International Expert Consensus on Optimized Clinical Use]]></article-title>
<source><![CDATA[Clin Chem Lab Med]]></source>
<year>2019</year>
<volume>57</volume>
<page-range>1308</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Mandal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Infectious Diseases Society of America / American Thoratic Society minor criteria for admission to the intensive care unit in patients with community-acquired pneumonia without major criteria or contraindications for the intensive care unit]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2011</year>
<volume>53</volume>
<page-range>503</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salih]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Schembri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Simplification of IDSA / ATS criteria for severe CAP using metaanalysis and observational data]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2014</year>
<volume>43</volume>
<page-range>842</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Light]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Girard]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkinson]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[George]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parapneumonic effusions]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>1980</year>
<volume>69</volume>
<page-range>507</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ort]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ryan]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Barden]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[D'Esopo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pneumococcal pneumonia in hospitalized patients Clinical and radiological presentations]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1983</year>
<volume>249</volume>
<page-range>214</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pande]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nasir]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The incidence ofnecrotizing changes in adults with pneumococcal pneumonia]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2012</year>
<volume>54</volume>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yangco]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Deresinski]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Necrotizing or cavitating pneumonia due to Streptococcus Pneumoniae report of four cases and review of the literature]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>1980</year>
<volume>59</volume>
<page-range>449</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alhazzani]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Alshamsi]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU]]></article-title>
<source><![CDATA[Critical Care Medicine]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jorwal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality among COVID-19 Patients- A Retrospective Study]]></article-title>
<source><![CDATA[Journal of Medical Science And clinical Research]]></source>
<year>2020</year>
<volume>08</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalil]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Metersky]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Klompas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo de adultos con neumonía adquirida en el hospital y asociada al respirador guías de práctica clínica de 2016 de la Infectious Diseases Society of America y la American Thoracic Society]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2016</year>
<volume>63</volume>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Bus]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Depuydt]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Steen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desescalada de antimicrobianos en el paciente critico y evaluación de la curación clínica el estudio DIANA]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2020</year>
<volume>46</volume>
<page-range>1404</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalil]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Metersky]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Klompas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo de adultos con neumonía adquirida en el hospital y asociada al respirador guías de práctica clínica de 2016 de la Infectious Diseases Society of America y la American Thoracic Society]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2016</year>
<volume>63</volume>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klompas]]></surname>
<given-names><![CDATA[Michael]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas Jr]]></surname>
<given-names><![CDATA[M File]]></given-names>
</name>
<name>
<surname><![CDATA[Bond]]></surname>
<given-names><![CDATA[Sheila]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[treatment-of-hospital- acquired-and-ventilator-associated-pneumonia-in-adults]]></source>
<year>2020</year>
<publisher-name><![CDATA[UpToDate]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
